Differential cognitive deterioration in dementia

A two year longitudinal study

Samuel R. Chamberlain, Andrew D. Blackwell, Pradeep J. Nathan, Geoff Hammond, Trevor W Robbins, John Russel Hodges, Albert Michael, James M. Semple, Edward T. Bullmore, Barbara Jenny Sahakian

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Other

Abstract

The ability to predict cognitive deterioration in patients with dementia holds valuable potential for clinical trials and early intervention. This study identified cognitive domains deteriorating differentially over time as well as baseline predictors of subsequent cognitive decline in patients referred to a memory clinic. Twenty-six subjects with Alzheimer’s disease (AD) and 43 subjects with Subjective Memory Impairment (SMI) were entered into a longitudinal study in which cognitive function was assessed at baseline and at 8-monthly intervals for 2 years, using a range of well-validated measures. Thirty-seven patients with depression and 39 healthy controls were also longitudinally assessed. AD was associated with disproportionate deterioration over time on general measures of cognitive function, multiple measures of mnemonic processing, mental fluency (letter and category), and aspects of motor speed. SMI showed restricted relative cognitive deterioration on general measures of cognitive function, on a subset of memory measures, and on letter but not category fluency. Secondary analysis showed that earliest detectable ADAS-cog and MMSE decline in AD was at 16 months, while several specific neuropsychological indices were sensitive as early as 8 months (graded naming test, semantic naming, and the category/letter fluency tests). In combination, baseline/early changes in cognitive performance, alongside clinical measures, predicted 48% of disease progression over two years in memory impaired patients as a whole. These findings have implications for identifying patients likely to benefit from disease modifying agents, and for designing, powering, enriching, and implementing future clinical trials. Follow-up studies in independent populations are needed to validate predictive algorithms identified.

Original languageEnglish
Title of host publicationHandbook of Depression in Alzheimer's Disease
EditorsGwenn S. Smith
PublisherIOS Press
Pages107-118
Number of pages12
Volume4
ISBN (Electronic)9781614995425
ISBN (Print)9781614995418
DOIs
Publication statusPublished - 1 Jan 2015
Externally publishedYes

Publication series

NameAdvances in Alzheimer's Disease
Volume4
ISSN (Print)22105727
ISSN (Electronic)22105735

Keywords

  • Alzheimer’s disease
  • Cognition
  • Dementia
  • Enrichment
  • Longitudinal
  • Prediction
  • Semantic

Cite this

Chamberlain, S. R., Blackwell, A. D., Nathan, P. J., Hammond, G., Robbins, T. W., Hodges, J. R., ... Sahakian, B. J. (2015). Differential cognitive deterioration in dementia: A two year longitudinal study. In G. S. Smith (Ed.), Handbook of Depression in Alzheimer's Disease (Vol. 4, pp. 107-118). (Advances in Alzheimer's Disease; Vol. 4). IOS Press. https://doi.org/10.3233/978-1-61499-542-5-107
Chamberlain, Samuel R. ; Blackwell, Andrew D. ; Nathan, Pradeep J. ; Hammond, Geoff ; Robbins, Trevor W ; Hodges, John Russel ; Michael, Albert ; Semple, James M. ; Bullmore, Edward T. ; Sahakian, Barbara Jenny. / Differential cognitive deterioration in dementia : A two year longitudinal study. Handbook of Depression in Alzheimer's Disease. editor / Gwenn S. Smith. Vol. 4 IOS Press, 2015. pp. 107-118 (Advances in Alzheimer's Disease).
@inbook{10a25988536347ff942d901b4e9e9d56,
title = "Differential cognitive deterioration in dementia: A two year longitudinal study",
abstract = "The ability to predict cognitive deterioration in patients with dementia holds valuable potential for clinical trials and early intervention. This study identified cognitive domains deteriorating differentially over time as well as baseline predictors of subsequent cognitive decline in patients referred to a memory clinic. Twenty-six subjects with Alzheimer’s disease (AD) and 43 subjects with Subjective Memory Impairment (SMI) were entered into a longitudinal study in which cognitive function was assessed at baseline and at 8-monthly intervals for 2 years, using a range of well-validated measures. Thirty-seven patients with depression and 39 healthy controls were also longitudinally assessed. AD was associated with disproportionate deterioration over time on general measures of cognitive function, multiple measures of mnemonic processing, mental fluency (letter and category), and aspects of motor speed. SMI showed restricted relative cognitive deterioration on general measures of cognitive function, on a subset of memory measures, and on letter but not category fluency. Secondary analysis showed that earliest detectable ADAS-cog and MMSE decline in AD was at 16 months, while several specific neuropsychological indices were sensitive as early as 8 months (graded naming test, semantic naming, and the category/letter fluency tests). In combination, baseline/early changes in cognitive performance, alongside clinical measures, predicted 48{\%} of disease progression over two years in memory impaired patients as a whole. These findings have implications for identifying patients likely to benefit from disease modifying agents, and for designing, powering, enriching, and implementing future clinical trials. Follow-up studies in independent populations are needed to validate predictive algorithms identified.",
keywords = "Alzheimer’s disease, Cognition, Dementia, Enrichment, Longitudinal, Prediction, Semantic",
author = "Chamberlain, {Samuel R.} and Blackwell, {Andrew D.} and Nathan, {Pradeep J.} and Geoff Hammond and Robbins, {Trevor W} and Hodges, {John Russel} and Albert Michael and Semple, {James M.} and Bullmore, {Edward T.} and Sahakian, {Barbara Jenny}",
year = "2015",
month = "1",
day = "1",
doi = "10.3233/978-1-61499-542-5-107",
language = "English",
isbn = "9781614995418",
volume = "4",
series = "Advances in Alzheimer's Disease",
publisher = "IOS Press",
pages = "107--118",
editor = "Smith, {Gwenn S.}",
booktitle = "Handbook of Depression in Alzheimer's Disease",
address = "Netherlands",

}

Chamberlain, SR, Blackwell, AD, Nathan, PJ, Hammond, G, Robbins, TW, Hodges, JR, Michael, A, Semple, JM, Bullmore, ET & Sahakian, BJ 2015, Differential cognitive deterioration in dementia: A two year longitudinal study. in GS Smith (ed.), Handbook of Depression in Alzheimer's Disease. vol. 4, Advances in Alzheimer's Disease, vol. 4, IOS Press, pp. 107-118. https://doi.org/10.3233/978-1-61499-542-5-107

Differential cognitive deterioration in dementia : A two year longitudinal study. / Chamberlain, Samuel R.; Blackwell, Andrew D.; Nathan, Pradeep J.; Hammond, Geoff; Robbins, Trevor W; Hodges, John Russel; Michael, Albert; Semple, James M.; Bullmore, Edward T.; Sahakian, Barbara Jenny.

Handbook of Depression in Alzheimer's Disease. ed. / Gwenn S. Smith. Vol. 4 IOS Press, 2015. p. 107-118 (Advances in Alzheimer's Disease; Vol. 4).

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Other

TY - CHAP

T1 - Differential cognitive deterioration in dementia

T2 - A two year longitudinal study

AU - Chamberlain, Samuel R.

AU - Blackwell, Andrew D.

AU - Nathan, Pradeep J.

AU - Hammond, Geoff

AU - Robbins, Trevor W

AU - Hodges, John Russel

AU - Michael, Albert

AU - Semple, James M.

AU - Bullmore, Edward T.

AU - Sahakian, Barbara Jenny

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The ability to predict cognitive deterioration in patients with dementia holds valuable potential for clinical trials and early intervention. This study identified cognitive domains deteriorating differentially over time as well as baseline predictors of subsequent cognitive decline in patients referred to a memory clinic. Twenty-six subjects with Alzheimer’s disease (AD) and 43 subjects with Subjective Memory Impairment (SMI) were entered into a longitudinal study in which cognitive function was assessed at baseline and at 8-monthly intervals for 2 years, using a range of well-validated measures. Thirty-seven patients with depression and 39 healthy controls were also longitudinally assessed. AD was associated with disproportionate deterioration over time on general measures of cognitive function, multiple measures of mnemonic processing, mental fluency (letter and category), and aspects of motor speed. SMI showed restricted relative cognitive deterioration on general measures of cognitive function, on a subset of memory measures, and on letter but not category fluency. Secondary analysis showed that earliest detectable ADAS-cog and MMSE decline in AD was at 16 months, while several specific neuropsychological indices were sensitive as early as 8 months (graded naming test, semantic naming, and the category/letter fluency tests). In combination, baseline/early changes in cognitive performance, alongside clinical measures, predicted 48% of disease progression over two years in memory impaired patients as a whole. These findings have implications for identifying patients likely to benefit from disease modifying agents, and for designing, powering, enriching, and implementing future clinical trials. Follow-up studies in independent populations are needed to validate predictive algorithms identified.

AB - The ability to predict cognitive deterioration in patients with dementia holds valuable potential for clinical trials and early intervention. This study identified cognitive domains deteriorating differentially over time as well as baseline predictors of subsequent cognitive decline in patients referred to a memory clinic. Twenty-six subjects with Alzheimer’s disease (AD) and 43 subjects with Subjective Memory Impairment (SMI) were entered into a longitudinal study in which cognitive function was assessed at baseline and at 8-monthly intervals for 2 years, using a range of well-validated measures. Thirty-seven patients with depression and 39 healthy controls were also longitudinally assessed. AD was associated with disproportionate deterioration over time on general measures of cognitive function, multiple measures of mnemonic processing, mental fluency (letter and category), and aspects of motor speed. SMI showed restricted relative cognitive deterioration on general measures of cognitive function, on a subset of memory measures, and on letter but not category fluency. Secondary analysis showed that earliest detectable ADAS-cog and MMSE decline in AD was at 16 months, while several specific neuropsychological indices were sensitive as early as 8 months (graded naming test, semantic naming, and the category/letter fluency tests). In combination, baseline/early changes in cognitive performance, alongside clinical measures, predicted 48% of disease progression over two years in memory impaired patients as a whole. These findings have implications for identifying patients likely to benefit from disease modifying agents, and for designing, powering, enriching, and implementing future clinical trials. Follow-up studies in independent populations are needed to validate predictive algorithms identified.

KW - Alzheimer’s disease

KW - Cognition

KW - Dementia

KW - Enrichment

KW - Longitudinal

KW - Prediction

KW - Semantic

UR - http://www.scopus.com/inward/record.url?scp=84947720523&partnerID=8YFLogxK

U2 - 10.3233/978-1-61499-542-5-107

DO - 10.3233/978-1-61499-542-5-107

M3 - Chapter (Book)

SN - 9781614995418

VL - 4

T3 - Advances in Alzheimer's Disease

SP - 107

EP - 118

BT - Handbook of Depression in Alzheimer's Disease

A2 - Smith, Gwenn S.

PB - IOS Press

ER -

Chamberlain SR, Blackwell AD, Nathan PJ, Hammond G, Robbins TW, Hodges JR et al. Differential cognitive deterioration in dementia: A two year longitudinal study. In Smith GS, editor, Handbook of Depression in Alzheimer's Disease. Vol. 4. IOS Press. 2015. p. 107-118. (Advances in Alzheimer's Disease). https://doi.org/10.3233/978-1-61499-542-5-107